Caris Life Sciences, Inc. (CAI) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Sep 23, 2026.
- Filings shown
- 20
- Open-market buys
- 2
- Open-market sells
- 5
- Buys, 10b5-1 box not checked
- 2 of 2
Counts cover the 20 most recent Form 4 filings Tradune holds for CAI (filed May 12 – Sep 23, 2026); the score below covers only the trailing 90 days (0 buys, 5 sells). SEC EDGAR Form 4 filings for CAI last checked Nov 21, 2026, 09:00 UTC; the latest CAI filing Tradune holds was filed Sep 23, 2026. This is not guaranteed to be the complete record — see CAI's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 3 filings Tradune holds for CAI filed Sep 4 – Sep 23, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
5 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 0 sales· 0 sh
- checkbox disclosed
- On filings with the box not checked
- 5 sales· 1,004,712 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| David Baxley SpetzlerPresident | 0 | 3 | — | 597,212 | −$14,834,107 |
| Brian J. BrilleOfficer (see filing) | 0 | 1 | — | 400,000 | −$12,132,080 |
| John Russel DentonOfficer (see filing) | 0 | 1 | — | 7,500 | −$238,626 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at CAI
Insiders reported 2 open-market purchases of CAI between May 12, 2026 and Sep 23, 2026, across 2 distinct buyers. The most recent purchase was reported by Jon Halbert (Director) on May 15, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 7,500 | $31.82 | 174,855 | −4.1% | Sep 22, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 400,000 | $2.44 | 630,303 | +174% | Sep 17, 2026 |
| Open-market sale 10b5-1 box not checked | 400,000 | $30.33 | 230,303 | −63% | Sep 17, 2026 |
| Option exercise Stock Option | 400,000 | — | — | — | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 250,000 | $2.44 | 1,302,083 | +24% | Sep 4, 2026 |
| Option exercise Stock Option | 250,000 | — | — | — | Sep 4, 2026 |
| Open-market sale 10b5-1 box not checked | 119,212 | $24.76 | 1,182,871 | −9.2% | Sep 4, 2026 |
| Open-market sale 10b5-1 box not checked | 84,900 | $25.32 | 1,052,083 | −7.5% | Sep 3, 2026 |
| Open-market sale 10b5-1 box not checked | 393,100 | $24.76 | 1,136,983 | −26% | Sep 3, 2026 |
| Option exercise | 1,000,000 | $2.44 | 1,530,083 | +189% | Sep 3, 2026 |
| Option exercise Stock Option | 1,000,000 | — | — | — | Sep 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 31,813 | +71% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 31,813 | +71% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 62,863 | +27% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 29,321 | +82% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 133,060 | +11% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 29,321 | +82% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 343,897 | +4.0% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 13,192 | — | 131,813 | +11% | Aug 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 68,000 | $14.56 | 704,598 (indirect) | +11% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,600 | $15.62 | 308,979 | +0.5% | May 29, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,600 | $15.62 | 17,729 | +9.9% | May 29, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 9,771 | $15.25 | 153,771 | −6.0% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 13,987 | $15.25 | 230,303 | −5.7% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 13,856 | $15.25 | 530,083 | −2.5% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 6,047 | $15.25 | 181,515 | −3.2% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 40,712 | $15.25 | 2,574,533 | −1.6% | May 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 31,050 | $16.15 | 49,671 | +167% | May 11, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to CAI's (Sep 23, 2026).
Frequently asked about CAI insider activity
How many insiders bought CAI stock in these Form 4 filings?
2 distinct insiders at Caris Life Sciences, Inc. reported 2 open-market purchases (Form 4 code P) of CAI shares between May 12, 2026 and Sep 23, 2026, the most recent filed by Jon Halbert (Director) on May 15, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for CAI?
The most recent Form 4 on this page was filed by John Russel Denton (Officer (see filing)) on Sep 23, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market CAI insider sale shown?
The largest open-market sale among the filings shown was 400,000 CAI shares at $30.33 (about $12,132,080) by Brian J. Brille (Officer (see filing)) on Sep 17, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent CAI insider purchases have the Form 4 10b5-1 box checked?
No. All 2 CAI open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Jon Halbert (Director) on May 15, 2026, 68,000 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for CAI — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.